Kapri Anandi, Gupta Nitin, Nain Sumitra
Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, India.
Agilent Technologies Pvt. Ltd., 181/46, Industrial Area, Phase-1, Chandigarh, India.
Scientifica (Cairo). 2022 Nov 8;2022:8239931. doi: 10.1155/2022/8239931. eCollection 2022.
Xanthine and its derivatives are considered a pharmacologically potential moiety that manifests immense biological activities. Owing to this much diversity in the biological field, this scaffold has fascinated the attention of many researchers around the globe to scrutinize its basic structure chemically as well as biologically. In recent years, xanthine derivatives have been used therapeutically in different pathological conditions due to their presence in day-to-day life. Herein, we review the recent progress in the synthesis of xanthine and its derivatives. Some of the widely used synthetic strategies such as (a) Traube's synthesis, (b) one-pot synthesis, (c) xanthine-anneleated synthesis, and (d) miscellaneous synthesis were compiled in this review paper. The results obtained from this review paper highlight the significance of various xanthine derivatives as possible leads to the development of new drugs. The data compiled in this review paper could help the medicinal chemist in designing new active compounds from the modification of the already existing compounds in the search for novel drug leads. This report concludes that the various synthetic procedures exemplified in this review paper may serve as a support system for the designing of new molecules with a xanthine scaffold. Thus, we hope that this molecule may serve as the prototype in order to find out more active xanthine derivatives.
黄嘌呤及其衍生物被认为是一种具有药理学潜力的基团,具有巨大的生物活性。由于其在生物领域具有如此丰富的多样性,这个骨架吸引了全球许多研究人员的关注,他们从化学和生物学角度对其基本结构进行了仔细研究。近年来,黄嘌呤衍生物因其在日常生活中的存在而被用于不同病理状况的治疗。在此,我们综述了黄嘌呤及其衍生物合成的最新进展。本综述论文汇编了一些广泛使用的合成策略,如(a)特劳贝合成法、(b)一锅合成法、(c)黄嘌呤环化合成法和(d)其他合成法。本综述论文所得结果突出了各种黄嘌呤衍生物作为新药开发潜在先导物的重要性。本综述论文汇编的数据可帮助药物化学家通过修饰现有化合物来设计新的活性化合物,以寻找新型药物先导物。本报告得出结论,本综述论文中举例的各种合成方法可为设计具有黄嘌呤骨架的新分子提供支持体系。因此,我们希望这个分子可作为原型,以便发现更多活性黄嘌呤衍生物。